FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2733994766> ?p ?o ?g. }

• W2733994766 endingPage "2594" @default.
• W2733994766 startingPage "2587" @default.
• W2733994766 abstract "BackgroundMolecular hydrogen (H2) acts as a therapeutic antioxidant. Inhalation of H2 gas (1-4%) was effective for the improvement of cerebral infarction in multiple animal experiments. Thus, for actual applications, a randomized controlled clinical study is desired to evaluate the effects of inhalation of H2 gas. Here, we evaluate the H2 treatment on acute cerebral infarction.MethodsThrough this randomized controlled clinical study, we assessed the safety and effectiveness of H2 treatment in patients with cerebral infarction in an acute stage with mild- to moderate-severity National Institute of Health Stroke Scale (NIHSS) scores (NIHSS = 2-6). We enrolled 50 patients (25 each in the H2 group and the control group) with a therapeutic time window of 6 to 24 hours. The H2 group inhaled 3% H2 gas (1 hour twice a day), and the control group received conventional intravenous medications for the initial 7 days. The evaluations included daily vital signs, NIHSS scores, physical therapy indices, weekly blood chemistry, and brain magnetic resonance imaging (MRI) scans over the 2-week study period.ResultsThe H2 group showed no significant adverse effects with improvements in oxygen saturation. The following significant effects were found: the relative signal intensity of MRI, which indicated the severity of the infarction site, NIHSS scores for clinically quantifying stroke severity, and physical therapy evaluation, as judged by the Barthel Index.ConclusionsH2 treatment was safe and effective in patients with acute cerebral infarction. These results suggested a potential for widespread and general application of H2 gas. Molecular hydrogen (H2) acts as a therapeutic antioxidant. Inhalation of H2 gas (1-4%) was effective for the improvement of cerebral infarction in multiple animal experiments. Thus, for actual applications, a randomized controlled clinical study is desired to evaluate the effects of inhalation of H2 gas. Here, we evaluate the H2 treatment on acute cerebral infarction. Through this randomized controlled clinical study, we assessed the safety and effectiveness of H2 treatment in patients with cerebral infarction in an acute stage with mild- to moderate-severity National Institute of Health Stroke Scale (NIHSS) scores (NIHSS = 2-6). We enrolled 50 patients (25 each in the H2 group and the control group) with a therapeutic time window of 6 to 24 hours. The H2 group inhaled 3% H2 gas (1 hour twice a day), and the control group received conventional intravenous medications for the initial 7 days. The evaluations included daily vital signs, NIHSS scores, physical therapy indices, weekly blood chemistry, and brain magnetic resonance imaging (MRI) scans over the 2-week study period. The H2 group showed no significant adverse effects with improvements in oxygen saturation. The following significant effects were found: the relative signal intensity of MRI, which indicated the severity of the infarction site, NIHSS scores for clinically quantifying stroke severity, and physical therapy evaluation, as judged by the Barthel Index. H2 treatment was safe and effective in patients with acute cerebral infarction. These results suggested a potential for widespread and general application of H2 gas." @default.
• W2733994766 created "2017-07-14" @default.
• W2733994766 creator A5000659295 @default.
• W2733994766 creator A5003790126 @default.
• W2733994766 creator A5004371434 @default.
• W2733994766 creator A5004502587 @default.
• W2733994766 creator A5008582966 @default.
• W2733994766 creator A5010540843 @default.
• W2733994766 creator A5013597165 @default.
• W2733994766 creator A5017997382 @default.
• W2733994766 creator A5031872896 @default.
• W2733994766 creator A5040777097 @default.
• W2733994766 creator A5044949829 @default.
• W2733994766 creator A5075222162 @default.
• W2733994766 creator A5079395697 @default.
• W2733994766 creator A5088414143 @default.
• W2733994766 date "2017-11-01" @default.
• W2733994766 modified "2023-09-30" @default.
• W2733994766 title "Hydrogen Gas Inhalation Treatment in Acute Cerebral Infarction: A Randomized Controlled Clinical Study on Safety and Neuroprotection" @default.
• W2733994766 cites W1989011562 @default.
• W2733994766 cites W1997700594 @default.
• W2733994766 cites W2003263443 @default.
• W2733994766 cites W2006711213 @default.
• W2733994766 cites W2020074777 @default.
• W2733994766 cites W2021225575 @default.
• W2733994766 cites W2055767424 @default.
• W2733994766 cites W2067465127 @default.
• W2733994766 cites W2093750655 @default.
• W2733994766 cites W2125948531 @default.
• W2733994766 cites W2135082935 @default.
• W2733994766 cites W2138595885 @default.
• W2733994766 cites W2143559754 @default.
• W2733994766 cites W2149188107 @default.
• W2733994766 cites W2150197616 @default.
• W2733994766 cites W2169657429 @default.
• W2733994766 cites W2172216441 @default.
• W2733994766 cites W2397977415 @default.
• W2733994766 cites W2466448612 @default.
• W2733994766 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.06.012" @default.
• W2733994766 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28669654" @default.
• W2733994766 hasPublicationYear "2017" @default.
• W2733994766 type Work @default.
• W2733994766 sameAs 2733994766 @default.
• W2733994766 citedByCount "90" @default.
• W2733994766 countsByYear W27339947662017 @default.
• W2733994766 countsByYear W27339947662018 @default.
• W2733994766 countsByYear W27339947662019 @default.
• W2733994766 countsByYear W27339947662020 @default.
• W2733994766 countsByYear W27339947662021 @default.
• W2733994766 countsByYear W27339947662022 @default.
• W2733994766 countsByYear W27339947662023 @default.
• W2733994766 crossrefType "journal-article" @default.
• W2733994766 hasAuthorship W2733994766A5000659295 @default.
• W2733994766 hasAuthorship W2733994766A5003790126 @default.
• W2733994766 hasAuthorship W2733994766A5004371434 @default.
• W2733994766 hasAuthorship W2733994766A5004502587 @default.
• W2733994766 hasAuthorship W2733994766A5008582966 @default.
• W2733994766 hasAuthorship W2733994766A5010540843 @default.
• W2733994766 hasAuthorship W2733994766A5013597165 @default.
• W2733994766 hasAuthorship W2733994766A5017997382 @default.
• W2733994766 hasAuthorship W2733994766A5031872896 @default.
• W2733994766 hasAuthorship W2733994766A5040777097 @default.
• W2733994766 hasAuthorship W2733994766A5044949829 @default.
• W2733994766 hasAuthorship W2733994766A5075222162 @default.
• W2733994766 hasAuthorship W2733994766A5079395697 @default.
• W2733994766 hasAuthorship W2733994766A5088414143 @default.
• W2733994766 hasBestOaLocation W27339947661 @default.
• W2733994766 hasConcept C126322002 @default.
• W2733994766 hasConcept C127413603 @default.
• W2733994766 hasConcept C168563851 @default.
• W2733994766 hasConcept C197934379 @default.
• W2733994766 hasConcept C2776954882 @default.
• W2733994766 hasConcept C2777798775 @default.
• W2733994766 hasConcept C2779450755 @default.
• W2733994766 hasConcept C2780645631 @default.
• W2733994766 hasConcept C42219234 @default.
• W2733994766 hasConcept C500558357 @default.
• W2733994766 hasConcept C535046627 @default.
• W2733994766 hasConcept C541997718 @default.
• W2733994766 hasConcept C71924100 @default.
• W2733994766 hasConcept C78519656 @default.
• W2733994766 hasConceptScore W2733994766C126322002 @default.
• W2733994766 hasConceptScore W2733994766C127413603 @default.
• W2733994766 hasConceptScore W2733994766C168563851 @default.
• W2733994766 hasConceptScore W2733994766C197934379 @default.
• W2733994766 hasConceptScore W2733994766C2776954882 @default.
• W2733994766 hasConceptScore W2733994766C2777798775 @default.
• W2733994766 hasConceptScore W2733994766C2779450755 @default.
• W2733994766 hasConceptScore W2733994766C2780645631 @default.
• W2733994766 hasConceptScore W2733994766C42219234 @default.
• W2733994766 hasConceptScore W2733994766C500558357 @default.
• W2733994766 hasConceptScore W2733994766C535046627 @default.
• W2733994766 hasConceptScore W2733994766C541997718 @default.
• W2733994766 hasConceptScore W2733994766C71924100 @default.
• W2733994766 hasConceptScore W2733994766C78519656 @default.
• W2733994766 hasIssue "11" @default.
• W2733994766 hasLocation W27339947661 @default.
• W2733994766 hasLocation W27339947662 @default.

• next